ArticleNature biomedical engineering2026
Implementing trust in non-small cell lung cancer diagnosis with a conformalized uncertainty-aware AI framework.
Article in Nature biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
- Update of
Authors and funding
9 authors.
Funding
Abstract
Ensuring trustworthiness is fundamental in cancer diagnostics, where a misdiagnosis can have dire consequences. Current pathology AI models lack systematic solutions to address trustworthiness concerns arising from model limitations and data discrepancies between model deployment and development environments. Here we introduce TRUECAM (Trustworthiness-focused, Uncertainty-aware, End-to-end Cancer diagnosis with Model-agnostic capabilities), a framework designed to ensure both data and model trustworthiness for non-small cell lung cancer subtyping with whole-slide images. TRUECAM integrates (1) a spectral-normalized neural Gaussian process for identifying out-of-scope inputs, (2) an ambiguity-guided tile elimination to filter out highly ambiguous regions, addressing data trustworthiness, and (3) conformal prediction to ensure controlled error rates. We systematically evaluated TRUECAM across multiple cancer datasets using both task-specific and foundation models. Computational experiments suggest that models wrapped with TRUECAM consistently outperformed their unwrapped counterparts in classification accuracy, robustness, interpretability, data efficiency and fairness. These findings establish TRUECAM as a versatile framework for the responsible deployment of pathology AI in real-world settings.
Identifiers
42337062What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.